Vote Scores

Home / Companies / Pharmaron Beijing Co., Ltd. / 20 Jun 2025

Meeting · year to 30 June 202529 filers reporting

Pharmaron Beijing Co., Ltd.: meeting of 20 Jun 2025

Votes reported on Form N-PX, item by item

29 Form N-PX filers reported votes at the Pharmaron Beijing Co., Ltd. meeting of 20 Jun 2025. Their records fall into 9 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

1 nominee; 100.0% of reported votes for; no filer withheld from or voted against at least one nominee.

16 vote records from 7 filers. 0 of the 7 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management7 filers
2

DIRECTOR ELECTIONSSecurity holder

Director elections (nominees put forward by security holders)

1 nominee; 100.0% of reported votes for; no filer withheld from or voted against at least one nominee.

57 vote records from 21 filers. 0 of the 21 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management21 filers
3

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

2 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management1 filers100.0% for0.0% against0.0% against management295,351 reported shares
4

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

154 vote records from 28 filers. 0 of the 28 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management28 filers100.0% for0.0% against0.0% against management30,384,306 reported shares
5

SHAREHOLDER RIGHTS AND DEFENSESIssuer

SHAREHOLDER RIGHTS AND DEFENSES: management items

Management items in this category are shown together; filers word and number them differently.

57 vote records from 21 filers. 0 of the 21 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management21 filers100.0% for0.0% against0.0% against management11,849,647 reported shares, counted once per item in this group
6

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

558 vote records from 28 filers. 0 of the 28 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management28 filers98.1% for1.9% against1.9% against management111,779,662 reported shares, counted once per item in this group
7

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

292 vote records from 28 filers. 0 of the 28 filers that marked the item either way voted against management.

35.7% for0.0% against64.3% other0.0% against management28 filers86.9% for13.1% against13.1% against management57,850,112 reported shares, counted once per item in this group
8

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

675 vote records from 28 filers. 0 of the 28 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management28 filers98.9% for1.1% against1.1% against management131,167,295 reported shares, counted once per item in this group
9

OTHERIssuer

OTHER: management items

Management items in this category are shown together; filers word and number them differently.

30 vote records from 3 filers. 0 of the 3 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management3 filers100.0% for0.0% against0.0% against management2,610,400 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Directors4. Auditor
VanguardNo reportForFor
BlackRock and iSharesForNo reportFor
FidelityNo reportForFor
DimensionalNo reportForFor
State Street and SPDRNo reportForFor
American CenturyNo reportForFor
Franklin TempletonNo reportForFor
EquitableNo reportForFor
Charles SchwabForNo reportFor
Nuveen and TIAANo reportForFor
John Hancock and ManulifeForNo reportFor
Morgan Stanley, Eaton Vance and CalvertNo reportForFor
Goldman SachsNo reportForFor
WisdomTreeNo reportForFor
Northern Trust and FlexSharesNo reportForFor
Lincoln FinancialNo reportForFor
BNY MellonNo reportForFor
Pacific Life fundsNo reportForFor
VanEckForNo reportFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Pharmaron Beijing Co., Ltd. meeting?

29 Form N-PX filers reported votes at the meeting of 20 Jun 2025. On say-on-pay, 0 of 1 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Pharmaron Beijing Co., Ltd. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Pharmaron Beijing Co., Ltd.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Pharmaron Beijing Co., Ltd. with a meeting date within three days of 20 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.